Palonosetron: — The Injection That Covers Delayed Nausea

Palonosetron is sold under the brand name Aloxi, which is the originator brand. Several generic versions are also available in India under different names. Your hospital pharmacy will dispense whichever formulation your oncologist has prescribed. The active medicine is the same across brands; the brand name is simply the label under which a particular manufacturer markets it.

Your team may have switched because your previous cycle caused delayed nausea — the kind that starts a day or more after treatment rather than immediately — or because your new chemotherapy carries a higher risk of that pattern. Palonosetron is designed to cover that delayed window more effectively. It is not a sign that something has gone wrong; it is the team adjusting the plan to fit your treatment and your experience.

For many people it reduces nausea significantly, but it does not always prevent it entirely. How much nausea you experience depends on the chemotherapy itself, your individual response, and what else is given alongside palonosetron. ASCO and NCCN guidance frames anti-nausea medicines as aiming to reduce and control nausea rather than to guarantee none at all. If you still feel sick after treatment, tell your team — the plan can be adjusted.

The most commonly reported side effects are headache, constipation, and dizziness. These are generally mild. Constipation is worth mentioning proactively — tell your team if it becomes a problem, because simple measures can help. Serious reactions are uncommon. If you notice anything unusual after the injection — a skin reaction, swelling, or feeling faint — tell your nurse before you leave the unit.

The injection form ensures the medicine reaches your bloodstream directly and is already active before your chemotherapy begins. A tablet taken at home would take time to absorb, and there is a risk you could vomit it before it works. Giving it intravenously in the clinic, just before the infusion starts, means the full effect is in place when your chemotherapy enters your body.

That depends on your regimen and how you have responded. Many people receive it before each cycle of chemotherapy that carries a significant risk of nausea. Your oncologist decides this based on your specific treatment and your individual experience. If palonosetron is not listed for a particular cycle, ask your nurse or oncologist rather than assuming it was left out by mistake.

Yes, and it usually is. ASCO and NCCN guidelines for moderately and highly emetogenic chemotherapy recommend combining palonosetron with dexamethasone, and sometimes a third medicine from a different class such as aprepitant or netupitant. Your team decides the combination based on your specific chemotherapy. Tell them everything else you are taking, including over-the-counter medicines and supplements, so they can check for any interactions.

Tell them exactly that: when the nausea started after treatment, how severe it was on each day, whether you vomited, and whether you could eat and drink. This pattern — nausea that continues or peaks a day or more after treatment — is delayed nausea, and it is specifically what palonosetron and medicines like aprepitant are intended to address. Knowing your exact experience lets your team decide whether to adjust your pre-treatment medicines or add something you can take at home after your next cycle.